Health● Elevated51m ago · Nov 10, 2026, 12:44 AM
GLP-1s must now include warning for potential increased risk of vision loss, FDA announces
GlobeAlert Desk · curated from CBS News · global
The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
2 Elevated
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Health
Not flagged as developing.
More in Health
Health44m agoTrevi outlines non-IPF-ILD Phase II start in Q1 2027 as cash runway extends into 2030Seeking Alpha TechHealth1h agoFDA warns of rare vision-loss side effect from GLP-1 drugsCBS NewsHealth1h agoVeterans Day campaign aims to erase $35M in medical debt for nation heroesmyfox28columbus.com · United StatesHealth4h agoFDA warns of rare ‘eye stroke’ risk from GLP-1 drugsThe Hill